TIDMMED

RNS Number : 3520O

Medaphor Group PLC

17 May 2018

MedaPhor Group plc

("MedaPhor" or the "Group" or the "Company")

AGM Statement

MedaPhor Group plc (AIM: MED), the intelligent ultrasound software and simulation company, will hold its Annual General Meeting today at 10.30 a.m. at IP Group Offices, The Walbrook Building, 25 Walbrook, London, EC4N 8AF. At the meeting the Chairman, Riccardo Pigliucci, will make the following statement:

"The Group is trading in line with management's expectations, research and development work being undertaken by our Clinical Division is progressing well and Simulation Division sales in the UK and mainland Europe are showing good signs of recovery. Initial orders placed in our key territories for our recently launched BodyWorks point of care and emergency medicine simulator are also encouraging."

A copy of this announcement is available on the Group's website: www.medaphor.com

 
 MedaPhor Group plc                                  www.medaphor.com 
 Stuart Gall, CEO                                 Tel: +44 (0)29 2075 
  Ian Whittaker, COO                                             6534 
 
 Cenkos Securities                                Tel: +44 (0)20 7397 
                                                                 8900 
 Camilla Hume (Nominated Advisor) 
 Michael Johnson / Julian 
  Morse (Corporate Broking) 
 
 Walbrook PR                              Tel: +44 (0)20 7933 8780 or 
                                              medaphor@walbrookpr.com 
 Paul McManus / Anna                  Mob: +44 (0)7980 541 893 / Mob: 
  Dunphy                                          +44 (0)7876 741 001

About MedaPhor (www.investors.medaphor.com)

MedaPhor (AIM: MED), the intelligent ultrasound software and simulation company, develops artificial intelligence-based clinical image analysis software tools, augmented reality-based needle guidance software and advanced hi-fidelity haptic and manikin-based training simulators for medical practitioners.

Based in Cardiff and Oxford in the UK and Atlanta in the US and Hong Kong in Asia, MedaPhor operates two divisions:

Intelligent Ultrasound Simulation Division

Focuses on hi-fidelity ultrasound education and training through simulation. Its three main products are the ScanTrainer OBGYN and General Medical simulator training platform, the HeartWorks echocardiography simulator platform and the BodyWorks Eve Point of Care and Emergency Medicine Simulator. Over 500 MedaPhor simulators have been sold to over 300 medical institutions in over 30 countries around the world.

Intelligent Ultrasound Clinical Division

Focuses on augmented reality and deep-learning based algorithms to make ultrasound machines smarter and more accessible. Products in development include ScanNav and NeedleGuide. ScanNav uses machine-learning based algorithms to automatically identify, grade and capture good ultrasound images. NeedleGuide aims to simplify ultrasound-guided needling by using deep learning and augmented reality to provide the user with pathway guidance and automated tracking for a range of medical procedures.

Some products in the pipeline may require US FDA approval, as such this material should be considered informational only and does not constitute an offer to sell or infer claims or benefits.

This information is provided by RNS

The company news service from the London Stock Exchange

END

AGMUNRURWSAVAUR

(END) Dow Jones Newswires

May 17, 2018 02:01 ET (06:01 GMT)

Intelligent Ultrasound (LSE:IUG)
Historical Stock Chart
From Apr 2024 to May 2024 Click Here for more Intelligent Ultrasound Charts.
Intelligent Ultrasound (LSE:IUG)
Historical Stock Chart
From May 2023 to May 2024 Click Here for more Intelligent Ultrasound Charts.